NDC 0597-0002

Aptivus

Tipranavir

Aptivus is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Tipranavir.

• Product ID: 0597-0002_3d3e31e9-8b19-4d95-ac47-fe42aee61cde
• NDC: 0597-0002
• Product Type: Human Prescription Drug
• Proprietary Name: Aptivus
• Generic Name: Tipranavir
• Dosage Form: Solution
• Route of Administration: ORAL
• Marketing Start Date: 2008-09-01
• Marketing Category: NDA / NDA
• Application Number: NDA022292
• Labeler Name: Boehringer Ingelheim Pharmaceuticals, Inc.
• Substance Name: TIPRANAVIR
• Active Ingredient Strength: 100 mg/mL
• Pharm Classes: HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0597-0002-01

1 BOTTLE, GLASS in 1 CARTON (0597-0002-01) > 95 mL in 1 BOTTLE, GLASS

• Marketing Start Date: 2008-09-08
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0597-0002-01 [00597000201]

Aptivus SOLUTION

• Marketing Category: NDA
• Application Number: NDA022292
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2008-09-08

Drug Details

Active Ingredients

Ingredient	Strength
TIPRANAVIR	100 mg/mL

OpenFDA Data

• SPL SET ID: 08982e49-d2eb-4b25-b01a-1be52fd669ef
• Manufacturer:
  • Boehringer Ingelheim Pharmaceuticals, Inc.
• UNII:
  • ZZT404XD09
• RxNorm Concept Unique ID - RxCUI:
  • 577212
  • 802321
  • 805515
  • 603378
• UPC Code:
  • 0305970003021

Pharmacological Class

• HIV Protease Inhibitors [MoA]
• Protease Inhibitor [EPC]

NDC Crossover Matching brand name "Aptivus" or generic name "Tipranavir"

NDC	Brand Name	Generic Name
0597-0002	Aptivus	tipranavir
0597-0003	Aptivus	tipranavir